Related Experiment Video
Updated: Aug 5, 2026
11:48
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Sirtuin 1 Is Required for Optimal Mammarenavirus Multiplication
Biorxiv : the Preprint Server for Biology
|August 1, 2026
Summary
Cambinol inhibits Lymphocytic choriomeningitis virus (LCMV) replication by disrupting multiple life cycle stages. Sirtuin-1 (Sirt-1) is identified as a host factor promoting LCMV multiplication, suggesting Sirt-1 inhibitors as potential antivirals.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Mammarenaviruses (MaAv), including Lymphocytic choriomeningitis virus (LCMV), cause persistent and zoonotic infections, posing significant public health challenges.
- Current therapeutic options for MaAv infections are limited, highlighting the need for novel antiviral strategies.
- Neutral sphingomyelinase 2 (nSMase2) and sirtuins (Sirt-1, Sirt-2) are host factors implicated in viral multiplication.
Purpose of the Study:
- To elucidate the antiviral mechanisms of cambinol against LCMV.
- To investigate the role of host factors nSMase2 and sirtuins in LCMV replication.
- To explore the potential of repurposing Sirt-1 inhibitors as host-directed antivirals (HDAs) against pathogenic MaAv.
Main Methods:
- Investigated cambinol's effects on various stages of the LCMV life cycle, including viral entry, replication, and assembly.
- Utilized knockout (KO) cell lines for SIRT1 and SIRT2 to assess their roles in LCMV multiplication.
- Assessed viral ribonucleoprotein (vRNP) activity and infectious progeny production in wild-type and KO cells.
Main Results:
- Cambinol inhibits LCMV cell entry by interfering with pH-dependent fusion mediated by the MaAv glycoprotein.
- Cambinol reduces viral genome replication and transcription, and impairs the budding activity of the viral matrix Z protein.
- Sirtuin-1 (Sirt-1) was identified as a pro-viral host factor essential for optimal LCMV multiplication, while Sirt-2 did not show a significant role.
Conclusions:
- Cambinol exhibits broad-spectrum antiviral activity against LCMV by targeting multiple steps in its life cycle.
- Sirt-1 is a critical host factor supporting LCMV replication, making it a potential therapeutic target.
- Sirt-1 inhibitors, currently in clinical development, represent a promising avenue for developing novel host-directed antivirals against pathogenic Mammarenaviruses.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...